Phase 1 Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are older than 6 months of age.
- Your leukemia (AML) cells have been tested and confirmed to carry certain specific markers called CLL-1, CD123, CD38, and/or CD33, identified through a lab test on a tissue or blood sample.
- You are generally in good health and able to carry out most daily activities, and doctors expect you to live for more than 3 months.
- Your heart, liver, and kidneys are working well enough to meet specific lab test thresholds (confirm exact values with the trial site).
- Your hemoglobin (a measure of red blood cells) is at an adequate level (at least 80 g/L).
- You do not have any medical reasons that would prevent a cell separation procedure (a process used to collect certain blood cells).
- You are able to understand the study and are willing to sign a consent form agreeing to take part.
Who may not be able to join:
- You have a serious illness or medical condition, including an active infection that is not under control, that would make it unsafe to follow the study plan.
- You have an active bacterial, fungal, or viral infection that has not been brought under control with treatment.
- You have a known HIV infection or an active Hepatitis C infection.
- You are currently pregnant or breastfeeding.
- You have taken steroid medications (glucocorticoids) as a whole-body treatment within one week before joining the trial.
- You have previously received any gene therapy treatment.
- More than 50% of your bone marrow is made up of leukemia cells at the time of joining.
- In the opinion of the study doctors, you may not be able to follow the study rules and requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 0755-86573763
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety of infusion
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.